Renalytix to Present at the 2021 Wells Fargo Virtual Healthcare Conference

Rhea-AI Summary

Renalytix, trading under the ticker RNLX, announced its participation in the 2021 Wells Fargo Virtual Healthcare Conference scheduled for September 10 at 2:40 p.m. EDT. This event will feature a fireside chat with the company’s management, accessible via a live and archived webcast on their website. Renalytix is a leader in bioprognosis for kidney health and has developed the KidneyIntelX™ technology, recognized for its potential in chronic kidney disease diagnostics. For more details, visit renalytix.com.

NEW YORK and SALT LAKE CITY, Sept. 03, 2021 (GLOBE NEWSWIRE) -- Renalytix plc (LSE: RENX) (NASDAQ: RNLX) (“Renalytix” or the “Company”) today announced the company will be presenting at the upcoming 2021 Wells Fargo Virtual Healthcare Conference.

Renalytix’s management is scheduled to participate in a fireside chat Friday, September 10 at 2:40 p.m. EDT. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at investors.renalytix.com.

About Renalytix
Renalytix (LSE: RENX) (NASDAQ: RNLX) Renalytix is the global founder and leader in the new field of bioprognosis™ for kidney health. The company has engineered a new solution that successfully enables early-stage chronic kidney disease, progression risk assessment. The Company’s lead product is KidneyIntelX™, has been granted Breakthrough Designation by the U.S. Food and Drug Administration and is designed to help make significant improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery (visit www.kidneyintelx.com). For more information, visit www.renalytix.com.

UK Investor Contact:

Walbrook PR Limited	Tel: 020 7933 8780 or renalytix@walbrookpr.com
Paul McManus / Lianne Cawthorne	Mob: 07980 541 893 / 07584 391 303

US Investor Contact:

CapComm Partners	investors@renalytix.com
Peter DeNardo		415-389-6400

FAQ

When will Renalytix present at the 2021 Wells Fargo Virtual Healthcare Conference?

Renalytix will present on September 10, 2021, at 2:40 p.m. EDT.

How can I access the Renalytix conference presentation?

The presentation can be accessed live and in archive at the 'Investors' section of the Renalytix website.

What are the key products of Renalytix?

Renalytix's lead product is KidneyIntelX™, designed for chronic kidney disease prognosis.

What is the significance of KidneyIntelX™?

KidneyIntelX™ has received Breakthrough Designation from the FDA for improving kidney disease management.

What stock exchange is Renalytix listed on?

Renalytix is listed on both the LSE and NASDAQ under the ticker RNLX.